Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in rats

被引:17
作者
Barocelli, E
Chiavarini, M
Ballabeni, V
Barlocco, D
Vianello, P
DalPiaz, V
Impicciatore, M
机构
[1] UNIV PARMA, FAC FARM, IST FARMACOL & FARMACOGNOSIA, I-43100 PARMA, ITALY
[2] UNIV MILAN, IST CHIM FARMACEUT & TOSSICOL, MILAN, ITALY
[3] UNIV FLORENCE, DIPARTIMENTO SCI FARMACEUT, PARMA, ITALY
关键词
in vivo in vitro functional assays; gastric mucosal barrier; antiulcer-antisecretory activity; indenopirydazinone derivative; ranitidine;
D O I
10.1006/phrs.1997.0168
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study investigates the antisecretory and antiulcer mechanisms of a new indenopyridazinone derivative previously reported to inhibit gastric acid secretion in pylorus-ligated rats and to prevent gastric ulcerations induced by indomethacin or ethanol in the same animal species, The new compound was tested on the acid hypersecretion induced by histamine, pentagastrin and bethanechol in in vivo and in vitro experimental models, Furthermore, its influence on the mucosal layer adhering the gastric wall in indomethacin-treated rats was considered. Ranitidine was selected as a reference drug, The results obtained demonstrated that the new molecule, at variance with ranitidine, exerts antiulcer activity mainly enhancing the gastric mucosal integrity and simultaneously inhibiting the gastric acid hypersecretion evoked exclusively by cholinergic pulses, Therefore, an involvement of a neuronal rather than an effectorial mechanism has been suggested. Due to these mechanisms of action it clearly differentiates from ranitidine and its possible application in the peptic disease resistant to Hz-blockers could be speculated. (C) 1997 The Italian Pharmacological Society.
引用
收藏
页码:487 / 492
页数:6
相关论文
共 20 条
[1]  
BARLOCCO D, 1994, 4INT S CHEM PHARM PY
[2]  
BARLOCCO D, 1997, IN PRESS DRUG DES DI
[3]   PHARMACOLOGICAL ANALYSIS OF THE PENTAGASTRIN-TIOTIDINE INTERACTION IN THE MOUSE ISOLATED STOMACH [J].
BLACK, JW ;
LEFF, P ;
SHANKLEY, NP .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (03) :589-599
[4]   H-2-RECEPTOR ANTAGONISTS PROTECT AGAINST ASPIRIN-INDUCED GASTRIC-LESIONS IN THE RAT [J].
BUNCE, KT ;
DALY, MJ ;
HUMPHRAY, JM ;
STABLES, R .
AGENTS AND ACTIONS, 1981, 11 (1-2) :167-170
[5]  
Corne S.J., 1974, J PHYSIOL-LONDON, V242, P116
[6]  
Furchgott R.F., 1972, Catecholamines, P283
[7]   CONTINUOUS RECORDING OF ACID GASTRIC SECRETION IN THE RAT [J].
GHOSH, MN ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1958, 13 (01) :54-61
[8]  
Goldschmiedt M., 1993, Gastrointestinal Disease, V5th edition, P524
[9]   MUCOSAL COATING AGENTS AND OTHER NONANTISECRETORY AGENTS - ARE THEY CYTOPROTECTIVE [J].
GUTH, PH .
DIGESTIVE DISEASES AND SCIENCES, 1987, 32 (06) :647-654
[10]   THE EFFECT OF CCKB/GASTRIN ANTAGONISTS ON STIMULATED GASTRIC-ACID SECRETION IN THE ANESTHETIZED RAT [J].
HAYWARD, NJ ;
HARDING, M ;
LLOYD, SAC ;
MCKNIGHT, AT ;
HUGHES, J ;
WOODRUFF, GN .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (04) :973-977